HPLC analysis revealed eight major phenolics, with gallic acid, chlorogenic acid, and daidzein being the predominant compounds...Molecular docking studies suggested that phenolic compounds effectively interact with the CDK4 active site, supporting their potential anticancer properties. These findings highlight B. aegyptiaca-derived SeNPs as promising candidates for biomedical applications.

Here, doxorubicin (DOX) and teriflunomide (Tfm) were used as therapeutic building blocks for the self-assembly of tumor-targeting, excipient-free nanoassemblies (DoT) that enhance ferroptosis induction in TNBC. Simultaneously, Tfm further devastated the intracellular ferroptosis defense system by suppressing DHODH and crippling the radical-trapping antioxidant capacity, thus evoking robust ferroptotic cell death in TNBC cells. The work presents a synergistic co-disruption strategy against dual ferroptosis defense systems, exhibiting significant potential for clinical applications.

P2, N=25, Completed, University Hospital, Rouen | Unknown status --> Completed

Inhibition of MG/Mϕ with long-term minocycline treatment attenuated the incidence of ICHs around bAVMs. Our study indicates that MG/Mϕ are involved in destabilization of KRAS-induced bAVM, leading to hemorrhagic conversion/ICH. Thus, modulation of MG/Mϕ may reduce ICH risk in bAVM patients.

P1/2, N=31, Active, not recruiting, M.D. Anderson Cancer Center | Trial completion date: Jan 2026 --> May 2026 | Trial primary completion date: Jan 2026 --> May 2026

ABPA should be considered in non-asthmatic patients with recurrent respiratory symptoms and elevated tumor markers. Serial monitoring of CEA/CA 19-9 may aid therapeutic assessment.

Furthermore, gene reporter assay confirmed that TUDCA inhibited the transcriptional activity of NF-κB and AP1. These results suggest that TUDCA could exert a potent anti-metastatic activity in PMA-stimulated HT-1080 cells through modulation of MMPs, MAPKs signaling pathway, and NF-κB and AP1 transcription factors.

P=N/A, N=300, Not yet recruiting, Nanjing Medical University

P2, N=94, Not yet recruiting, University Hospital, Montpellier

P1, N=24, Recruiting, Stanford University | Not yet recruiting --> Recruiting

Complementary transcriptomic analysis using a compact four-gene Tα1 Response Index (Tα1-RI: TLR9, TLR2, IRF1, NLRC5) in TCGA-BRCA (n = 1,112) confirmed positive correlations with antigen presentation and cytotoxic programs and enrichment in CD8-like T cells in single-cell datasets. Collectively, these findings demonstrate that Tα1 enhances CD8+ T cell cytotoxicity while alleviating exhaustion, supporting its potential as an adjunct immunomodulator for improving immune surveillance in breast cancer.

P=N/A, N=340, Not yet recruiting, Northern Jiangsu People's Hospital; Northern Jiangsu People's Hospital